The effect of selective serotonin reuptake inhibitors on cognitive function in patients with alzheimer’s disease and vascular dementia: Focusing on fluoxetine with long follow-up periods

Signal Transduction and Targeted Therapy

Volumn 4, Issue 1, 2019, Pages

  Xie, Yi ^a   Liu, Pei Pei ^a   Lian, Ya Jun ^a   Liu, Hong Bo ^a   Kang, Jian Sheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ALZHEIMER DISEASE; COGNITION; DEMENTIA; FOLLOW UP; HIPPOCAMPUS; HUMAN; LETTER; META ANALYSIS (TOPIC); MINI MENTAL STATE EXAMINATION; MORTALITY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS;

EID: 85078680922     PISSN: 20959907     EISSN: 20593635     Source Type: Journal    
DOI: 10.1038/s41392-019-0064-7     Document Type: Letter

References (10)

1. Li, X. S. The curative effects of fluoxetine on vascular dementia. J. Linyi Med. Coll. 27, 435–437 (2005).
2. Mowla, A., Mosavinasab, M., Haghshenas, H. & Haghighi, A. B. Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer’s dementia? A double-blind, placebo-controlled clinical trial. J. Clin. Psychopharmacol. 27, 484–487 (2007).
3. Mowla, A., Mosavinasab, M. & Pani, A. Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial. J. Clin. Psychopharmacol. 27, 67–70 (2007).
4. Zhao, R. X. & Ren, A. H. Effect of different doses of fluoxetine in the treatment of vascular dementia. J. Huaihai Med. 27, 425 (2009).
5. Liu, X. et al. Effects of fluoxetine on brain-derived neurotrophic factor serum concentration and cognition in patients with vascular dementia. Clin. Interv. Aging 9, 411–418 (2014).
6. Sepehry, A. A., Lee, P. E., Hsiung, G. Y., Beattie, B. L. & Jacova, C. Effect of selective serotonin reuptake inhibitors in Alzheimer’s disease with comorbid depression: a meta-analysis of depression and cognitive outcomes. Drugs Aging 29, 793–806 (2012).
7. Jones, H. E., Joshi, A., Shenkin, S. & Mead, G. E. The effect of treatment with selective serotonin reuptake inhibitors in comparison to placebo in the progression of dementia: a systematic review and meta-analysis. Age Ageing 45, 448–456 (2016).
8. Wang, Y. C. et al. Increased risk of dementia in patients with antidepressants: a meta-analysis of observational studies. Behav. Neurol. 2018, 5315098 (2018).
9. Kessing, L. V., Sondergard, L., Forman, J. L. & Andersen, P. K. Antidepressants and dementia. J. Affect. Disord. 117, 24–29 (2009).
10. Liu, P.-P., Xie, Y. & Kang, J.-S. History and progress of hypotheses and clinical trials for Alzheimer’s disease. Signal Transduct. Target. Ther. https://doi.org/10.1038/s41392-019-0063-8 (2019).